PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $45,430 | -27.9% | 3,049 | -12.3% | 0.00% | -33.3% |
| Q4 2023 | $62,987 | +4.4% | 3,478 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $60,309 | +7.7% | 3,478 | +12.6% | 0.00% | 0.0% |
| Q2 2023 | $55,973 | -43.3% | 3,089 | -57.7% | 0.00% | +200.0% |
| Q4 2021 | $98,685 | -20.0% | 7,310 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $123,393 | -42.0% | 7,310 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $212,867 | -22.1% | 7,310 | +5.2% | 0.00% | -25.0% |
| Q1 2021 | $273,265 | +259.4% | 6,948 | +107.6% | 0.00% | +300.0% |
| Q4 2020 | $76,044 | +0.3% | 3,347 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $75,810 | – | 3,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mass General Brigham, Inc | 288,690 | $3,103,418 | 15.11% |
| TRV GP IV, LLC | 2,132,867 | $22,928,320 | 11.34% |
| Blue Owl Capital Holdings LP | 3,004,199 | $32,295,139 | 8.98% |
| GREAT POINT PARTNERS LLC | 2,636,864 | $28,346,288 | 5.43% |
| First Light Asset Management, LLC | 3,401,213 | $36,563,040 | 3.20% |
| Redmile Group, LLC | 3,209,591 | $34,503,103 | 2.09% |
| Deep Track Capital, LP | 5,972,257 | $64,201,763 | 1.92% |
| Fernwood Investment Management, LLC | 496,286 | $5,335,075 | 1.66% |
| Checkpoint Capital L.P. | 232,200 | $2,496,150 | 1.50% |
| Exome Asset Management LLC | 124,000 | $1,333,000 | 1.16% |